Christian Meyer

9PUBLICATIONS
127CO-AUTHORS
Gene and molecular therapyPeripheral nervous systemCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 08, 2026
SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST).

AeRang Kim, Karla V Ballman, Pamela L Wolters

|Aug 02, 2024
Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.

R Taylor Sundby, Jeffrey J Szymanski, Alexander C Pan

|Apr 29, 2024
Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma.

Brian A Van Tine, Matthew A Ingham, Steven Attia

|Mar 02, 2023
Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer.

Channing J Paller, Lin Wang, Wei Fu

|May 16, 2022
Bone Metastases in Patients with Leiomyosarcoma: A Retrospective Analysis of Survival and Surgical Management.

Christa L LiBrizzi, Ashish Vankara, Christian F Meyer

|Apr 08, 2022
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.

Mrinal M Gounder, Albiruni Abdul Razak, Neeta Somaiah

Pageof 2